Thursday, March 23, 2023
In the United States, cytomegalovirus (CMV) is the leading congenital viral infection, affecting approximately 1 in every 200 babies. Fortunately, in most cases, patients have no symptoms or disabilities. However, about 10% of the newborns who test positive are symptomatic. In these patients, congenital CMV can be associated with long-term neurodevelopment sequelae, such as sensorineural hearing loss, cerebral palsy, and intellectual disability. Listen to experts in this podcast series discuss what clinicians need to know about congenital CMV, including pathophysiology, evolution in pregnancy, newborn screening, a patient's experience, prevention strategies, and how to build a healthcare team.
Disclaimer
The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred. The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.
Medscape Education© Medscape, LLC
Listen to cytomegalovirus (CMV) experts discuss how to educate parents whose newborn has tested for positive for congenital
CMV
Listen to a parent discuss her journey with her newborn being diagnosed with congenital cytomegalovirus (CMV).